IHS Chemical Week

World News and Views :: Projects

Lonza to Acquire Stake in German Biotech Firm

11:58 PM MDT | October 22, 2009 | Deepti Ramesh

Lonza says it has signed an investment agreement, including a right of first refusal for the commercial production of products, with innovative biotechnology company Cilian (Münster, Germany).  Cilian uses the abilities of ciliates, eukaryotic single-cell micro-organisms, specifically the strain tetrahymena thermophila, for the production of therapeutic proteins and nutritional ingredients. Lonza owns a number of patents and patent applications in the field of tetrahymena thermophila and will transfer these patents and patent applications to Cilian. In...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa